Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Biontech Se ADR (BNTX)

Biontech Se ADR (BNTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 25,909,362
  • Shares Outstanding, K 237,766
  • Annual Sales, $ 4,133 M
  • Annual Income, $ 1,007 M
  • EBIT $ -932 M
  • EBITDA $ -734 M
  • 60-Month Beta 0.26
  • Price/Sales 6.41
  • Price/Cash Flow 21.99
  • Price/Book 1.29

Options Overview Details

View History
  • Implied Volatility 41.64% ( +0.09%)
  • Historical Volatility 22.92%
  • IV Percentile 88%
  • IV Rank 43.01%
  • IV High 61.53% on 09/13/24
  • IV Low 26.62% on 05/17/24
  • Put/Call Vol Ratio 0.75
  • Today's Volume 96
  • Volume Avg (30-Day) 1,176
  • Put/Call OI Ratio 0.90
  • Today's Open Interest 65,453
  • Open Int (30-Day) 67,204

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 13 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/24
See More
  • Average Estimate 2.94
  • Number of Estimates 7
  • High Estimate 6.07
  • Low Estimate 0.47
  • Prior Year 2.05
  • Growth Rate Est. (year over year) +43.41%

Price Performance

See More
Period Period Low Period High Performance
1-Month
107.19 +3.08%
on 11/04/24
124.00 -10.90%
on 10/07/24
-12.19 (-9.94%)
since 10/04/24
3-Month
76.84 +43.79%
on 08/06/24
131.49 -15.97%
on 09/17/24
+32.13 (+41.00%)
since 08/05/24
52-Week
76.53 +44.37%
on 08/05/24
131.49 -15.97%
on 09/17/24
+14.71 (+15.36%)
since 11/03/23

Most Recent Stories

More News
BioNTech Se (BNTX) Q3 2024 Earnings Call Transcript

BNTX earnings call for the period ending September 30, 2024.

BNTX : 110.30 (+1.22%)
Up Over 600% in 2024, Can Summit Therapeutics Stock Keep Rising?

This drugmaker's lead candidate could become a top-selling cancer therapy.

TIL : 27.72 (+0.33%)
SMMT : 20.46 (+2.51%)
BNTX : 110.30 (+1.22%)
4 Reasons Pfizer Could Be a Value Play You Can't Miss

Pfizer Inc. (NYSE: PFE) hit its peak during the COVID-19 pandemic when its vaccines developed with BioNTech SE (NASDAQ: BNTX) sent shares surging up to $61.71

HLN : 9.74 (-0.20%)
PFE : 27.79 (+0.11%)
BNTX : 110.30 (+1.22%)
Pfizer Canada and BioNTech Receive Health Canada Approval of Omicron KP.2 Variant Adapted COVID-19 Vaccine

/CNW/ - Pfizer Canada ULC and BioNTech SE (Nasdaq: BNTX, "BioNTech") announced today that Health Canada has authorized the KP.2 variant adapted COMIRNATY®...

PFE : 27.79 (+0.11%)
BNTX : 110.30 (+1.22%)
Here's Why Everyone's Talking About Summit Therapeutics

Find out why positive results from a Summit Therapeutics study keep pushing up BioNTech and Instil Bio stock.

SMMT : 20.46 (+2.51%)
TIL : 27.72 (+0.33%)
BNTX : 110.30 (+1.22%)
Should You Buy Novavax Stock After This Regulatory Win?

The biotech continues to earn important wins, but is it enough?

MRNA : 53.63 (+0.17%)
BNTX : 110.30 (+1.22%)
JNJ : 157.70 (-0.34%)
PFE : 27.79 (+0.11%)
NVAX : 9.30 (+1.97%)
SNY : 52.67 (-0.53%)
Analysts Predict Strong Growth for Cancer Vaccine Market: Key Biotech Stocks to Consider

Issued on behalf of BioVaxys Technology Corp. VANCOUVER – USA News Group – Back in 2022, Nature published...

BIOV.CN : 0.0700 (unch)
BVAXF : 0.0599 (+10.93%)
BNTX : 110.30 (+1.22%)
CVAC : 2.75 (+1.48%)
VXRT : 0.7291 (+0.57%)
IBRX : 5.23 (+0.58%)
New Research Reveals Emergence of New Variants of Coronavirus to Boost COVID-19 Therapeutics Market Growth

EQNX::TICKER_START (NASDAQ:SBFM),(NASDAQ:NVAX),(NASDAQ:RGNX),(NASDAQ:BNTX),(NYSE:ABBV) EQNX::TICKER_END

SBFM : 2.84 (-1.73%)
NVAX : 9.30 (+1.97%)
RGNX : 8.84 (+0.91%)
BNTX : 110.30 (+1.22%)
ABBV : 201.03 (+0.28%)
New Research Reveals Emergence of New Variants of Coronavirus to Boost COVID-19 Therapeutics Market Growth

SBFM : 2.84 (-1.73%)
NVAX : 9.30 (+1.97%)
RGNX : 8.84 (+0.91%)
BNTX : 110.30 (+1.22%)
ABBV : 201.03 (+0.28%)
Pfizer and BioNTech's Combo Shot Missed the Mark. Is It Time to Sell?

A clinical-trial failure for Pfizer and BioNTech means Moderna is leading the race to develop a combo shot for the flu and COVID-19.

PFE : 27.79 (+0.11%)
BNTX : 110.30 (+1.22%)
MRNA : 53.63 (+0.17%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Buy with a Weakening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

BioNTech SE is a biotechnology company. It develops and commercializes immunotherapies for cancer and other diseases. BioNTech SE is based in Mainz, Germany.

See More

Key Turning Points

3rd Resistance Point 119.69
2nd Resistance Point 116.84
1st Resistance Point 112.90
Last Price 110.30
1st Support Level 106.11
2nd Support Level 103.26
3rd Support Level 99.32

See More

52-Week High 131.49
Fibonacci 61.8% 110.50
Last Price 110.30
Fibonacci 50% 104.01
Fibonacci 38.2% 97.52
52-Week Low 76.53

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar